Data broker RELX is represented on Twitter by their Chief Communications Officer Paul Abrahams. Due to RELX subsidiary Elsevier being one of the largest publishers of academic journals, Dr. Abrahams frequently engages with academics on the social media platform. On their official pages, Elsevier tries to emphasize that they really, really can be trusted, honestly:
In fact, if one searches for “trust” with Elsevier, one may be forgiven for getting the impression that Elsevier is obsessed with trying to appear as if they were trustworthy:
For anyone following Elsevier’s endless list of transgressions, is not difficult to understand this obsession: academics routinely call the company “Evilsevier” for more reasons than there are bits on the internet (see, e.g., their Wikipedia page). With so many parasitic or outright hostile actions consistently directed at academics and academic institutions over decades, it really is prudent to at least try and provide an outwardly trustworthy face to the unsuspecting early career researcher who may not have heard of ‘Evilsevier’, yet. A wolf in sheep’s clothing:
The fact that Elsevier fits the consensus definition of a “predatory publisher” so well is thus only one of many reasons why data kraken Elsevier is so reviled in the academic community, but a reminder of it seems to have triggered the “we really can be trusted, honestly, this time” wolf-in-sheep-clothing-reflex in the RELX CCO Dr. Abrahams, such that he responded:
Apparently, he tried to make the claim that so many researchers author in and cite Elsevier journals that this must be evidence they trust Elsevier. He went on to make three very specific claims, which are worth examining:
As Paul Abrahams is tweeting in his capacity as “Chief Communications Officer at RELX”, let’s fact-check his three statements, one by one, as an example of just how trustworthy such public statements from RELX/Elsevier can be.
1. “Elsevier provides above-average quality…”
Let’s pretend, for now, RELX were not chiefly a surveillance platform and data broker enabling ICE mass deportations (some quality!), but instead an academic publisher (via subsidiary Elsevier) with above average overall impact (according to the citation numbers Dr. Abrahams posted himself, see above). In that case, given the negative relation between impact/prestige and quality, the available data suggest that Elsevier actually provides *below average* quality. So the first statement is contradicted by the available evidence. Of course, it may also be that Elsevier journals aren’t as impactful as their CCO claims, in which case his previous statement would be false. Either way, both cannot be correct at the same time.
2. “…for below average prices”
From the Q&A on occasion of the release of the latest 2022 RELX financial statement, and from Dr. Abraham’s tweet above, we learn that Elsevier published 600,000 articles the past year yielding a revenue of 2,909 £ million. Accordingly, an average article from Elsevier cost the tax payer 4,848£ or US$5,850. Which, even if one assumes the upper bound average cost of an article at US$5,000, is more than average. Also the second statement can be easily falsified, this time using RELX’s own numbers.
3. “You just don’t think the private sector should be involved in the diffusion of scholarly knowledge.”
Let’s take a recent article on the topic with me as a co-author and check the abstract: “It [the journal replacement] needs to replace the monopolies of current journals with a genuine, functioning and well-regulated market. In this new market, substitutable service providers compete and innovate”. Quite demonstrably, we argue for a market and the article text clearly states “traditional businesses” as competing as service providers in this market. So also this statement is obviously false. Interestingly, Paul “Chief Communications Officer at RELX” Abrahams seems to interpret our proposal of a “genuine market” as a threat to their monopoly and rightfully so: an actual market does threaten Elsevier’s gargantuan profit margins (37.8% in 2022, see above financial statement) with competition, something they fear deeply, as they have never had to deal with it in the history of their company. Quite apparently, Elsevier fear the mere proposal of competition so much, they attempt to smear it with misrepresentations by the Chief Communications Officer of their parent company.
So all three statements by the CCO of RELX turned out to be demonstrably false. Not surprising for the most reviled corporation in academia, where probably one of the least damning qualities is that they also fit the consensus definition of a predatory publisher. If Paul Abrahams keeps his job (as one would strongly suspect), it only serves to confirm that such false statements are part and parcel of the strategy with which RELX communicates with academics – and that one should never assume any engagement with them will be in good faith.
i love the wolf picture. who is the artist?
The artist is David Parkins. The credit is in the original post:
https://bjoern.brembs.net/2019/12/elsevier-now-officially-a-predatory-publisher/
He never reacted to my requests for re-use. The original is from:
https://www.nature.com/articles/d41586-019-03759-y
Dear Professor Brembs,
Let me try to answer the comments above.
1. Above average quality. Elsevier publishes 18% of STM articles and generates 28% of citations. The field weighted citation index for articles published by Elsevier between 2016 and 2020 is 1.42, which means that it is 42% above the industry average. The scores for the other three largest publishers are 1.01, 1.23 and 0.88. The share of articles in the top 10% journal field weighted citation index tier is 32%, and 96% are in the top half. 224 of 225 science and economics Nobel prize winners since 2000 have published in an Elsevier journal. Elsevier isn’t perfect, but it makes every effort to make its journals as good as it can. That’s one of the reasons that last year it received almost 2.7m submissions, while 18m unique users chose to download about 1.8bn articles from ScienceDirect – about six every second.
2, Below average prices. Elsevier’s stated strategy is to provide above average quality at below average prices. Unfortunately, the analysis you have published above is faulty. Elsevier did indeed publish 600,000 articles last year – compared with about 300,000 a decade ago. However, less than half of Elsevier’s revenues come from academic journals (primary research). So, using your methodology you would need to divide by at least two to come up with something even approximately accurate. In fact, Elsevier publishes more articles and at higher quality relative to other major publishers, yet its average list price per subscription article remains lower (by 2-3 times) than that of others. Since 2010, the number of articles submitted to Elsevier journals grew at a compound annual growth rate by 11%, and the volume of subscription articles published increased by 5%. Its average list price per subscription article grew by just 0.2% over that time (2011-2021) across its entire portfolio of journals. You can read the details here: https://www.elsevier.com/about/policies/pricing
3. You and I have been debating backwards forwards for many years about definitions of monopolies. The academic journals market is in fact highly fragmented and competitive. The top four publishers have a market share of about 40%, which is not concentrated at all (compare mobile telephony in the US where the top four have 99% share, for example). The barriers to entry are also low – witness the rapid growth of MPDI, Frontiers and Hindawi over the past decade. Between 2016 and 2020, MDPI increased the number of articles it published from 20,000 a year to over 140,000. The fragmented nature of the market and the low barriers to entry are some of the reasons why your complaints last decade to competition authorities did not result in any investigation.
Finally, Elsevier’s aim is to meet customer needs. The company now publishes over 700 Open Access journals, and nearly all its other titles have an open access option. So if authors want to publish Open Access with Elsevier they have that choice. Last year, the company published over 150,000 open access articles, up 26% on the previous year.
There is obviously an asymmetry between what an individual professor feels free to say, and how someone at a corporation can respond, but please believe that we endeavor to ensure that the information we provide is as accurate as possible.
Yours sincerely,
Paul Abrahams
Thanks for the reply. I had hoped to be able to elicit a ballpark figure for how much revenue E actually generates out of old-fashioned publishing these days and how much is coming from snooping. Good to have the confirmation that Elsevier is effectively reversing the flow of information.
Comments are closed.